$289.33
4.351.53%
À la fermeture: -
$288.91
-0.42-0.15%
Après les heures de négociation: 4:03 PM EDT
Amgen publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | AMGN | Amgen | FY | 2025 | $20.20 | $21.30 | $20.89 | $35.00B | $36.00B | $35.29B | |
05/01/2025 | AMGN | Amgen | FY | 2025 | $20.00 | $21.20 | $20.89 | $34.30B | $35.70B | $35.29B | |
02/04/2025 | AMGN | Amgen | FY | 2025 | $20.00 | $21.20 | $20.89 | $34.30B | $35.70B | $35.29B | |
10/30/2024 | AMGN | Amgen | FY | 2024 | $19.20 | $20.00 | $19.59 | $33.00B | $33.80B | $33.19B | |
08/06/2024 | AMGN | Amgen | FY | 2024 | $19.10 | $20.10 | $19.59 | $32.80B | $33.80B | $33.19B | |
05/02/2024 | AMGN | Amgen | FY | 2024 | $19.00 | $20.20 | $19.59 | $32.50B | $33.80B | $33.19B | |
02/06/2024 | AMGN | Amgen | FY | 2024 | $18.90 | $20.30 | $20.00 | $32.40B | $33.80B | $32.66B | |
10/31/2023 | AMGN | Amgen | FY | 2023 | $18.20 | $18.80 | $17.31 | $28.00B | $28.40B | $25.99B | |
08/03/2023 | AMGN | Amgen | FY | 2023 | $17.80 | $18.80 | $17.75 | $26.60B | $27.40B | $26.56B | |
04/27/2023 | AMGN | Amgen | FY | 2023 | $17.60 | $18.70 | $17.72 | $26.20B | $27.30B | $26.70B | |
01/31/2023 | AMGN | Amgen | FY | 2023 | $17.40 | $18.60 | $17.68 | $26.00B | $27.20B | $26.25B | |
11/03/2022 | AMGN | Amgen | FY | 2022 | $17.25 | $17.85 | $17.50 | $26.00B | $26.30B | $26.14B | |
08/04/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.40 | $25.50B | $26.40B | $26.23B | |
04/27/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.63 | $25.40B | $26.50B | $26.14B | |
02/08/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.83 | — | — | — | |
11/02/2021 | AMGN | Amgen | FY | 2021 | $16.50 | $17.10 | $16.43 | $25.80B | $26.20B | $26.01B | |
08/03/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.34 | $25.80B | $26.60B | $26.04B | |
04/27/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.80 | $25.80B | $26.60B | $26.41B | |
03/04/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.85 | $25.80B | $26.60B | $26.47B | |
02/02/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $17.02 | $25.80B | $26.60B | $26.43B |
Les dernières prévisions pour Amgen (AMGN) ont été communiquées le août 5, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $20.20 à $21.30, par rapport à un BPA estimé de $20.89. De plus, Amgen a prévu un chiffre d'affaires entre $35.00B et $36.00B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.